Related Experiment Video
Updated: Aug 16, 2026

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis
Isaiah R Turnbull1, Jonathan E McDunn, Toshiyuki Takai
1Department of Pathology and Immunology, Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110.
Abstract:
DAP12 (KARAP) is a transmembrane signaling adaptor for a family of innate immunoreceptors that have been shown to activate granulocytes and monocytes/macrophages, amplifying production of inflammatory cytokines. Contrasting with these data, recent studies suggest that DAP12 signaling has an inhibitory role in the macrophage response to microbial products (Hamerman, J.A., N.K. Tchao, C.A. Lowell, and L.L. Lanier. 2005. Nat. Immunol. 6:579-586). To determine the in vivo role for DAP12 signaling in inflammation, we measured the response of wild-type (WT) and DAP12-/- mice to septic shock. We show that DAP12-/- mice have improved survival from both endotoxemia and cecal ligation and puncture-induced septic shock. As compared with WT mice, DAP12-/- mice have decreased plasma cytokine levels and a decreased acute phase response during sepsis, but no defect in the recruitment of cells or bacterial control. In cells isolated after sepsis and stimulated ex vivo, DAP12 signaling augments lipopolysaccharide-mediated cytokine production. These data demonstrate that, during sepsis, DAP12 signaling augments the response to microbial products, amplifying inflammation and contributing to mortality.
Insights
DAP12 signaling amplifies inflammation and mortality during sepsis. Mice lacking DAP12 (DNAX-activating protein 12) showed improved survival and reduced inflammatory responses in septic shock models.
Area of Science:
- Immunology
- Innate Immunity
- Inflammation
Background:
- DAP12 (DNAX-activating protein 12) is a signaling adaptor for innate immunoreceptors.
- Previous studies suggested both activating and inhibitory roles for DAP12 in immune responses.
- Its in vivo role in inflammation, particularly during sepsis, remained unclear.
Purpose of the Study:
- To investigate the in vivo role of DAP12 signaling in the context of septic shock.
- To determine whether DAP12 signaling influences survival, cytokine production, and immune cell responses during sepsis.
Main Methods:
- Utilized wild-type (WT) and DAP12 knockout (DAP12-/-) mouse models.
- Induced septic shock using endotoxemia and cecal ligation and puncture (CLP) models.
- Assessed survival rates, plasma cytokine levels, acute phase response, cellular recruitment, bacterial control, and ex vivo cytokine production.
Main Results:
- DAP12-/- mice exhibited significantly improved survival rates in both endotoxemia and CLP-induced septic shock models compared to WT mice.
- DAP12-/- mice displayed reduced plasma cytokine levels and a diminished acute phase response during sepsis.
- No defects were observed in cellular recruitment or bacterial control in DAP12-/- mice.
- Ex vivo stimulation of cells from septic mice showed that DAP12 signaling augments lipopolysaccharide-induced cytokine production.
Conclusions:
- DAP12 signaling plays a critical role in augmenting inflammatory responses to microbial products during sepsis.
- This augmentation of inflammation by DAP12 contributes to mortality in septic shock.
- Targeting DAP12 signaling may offer a therapeutic strategy to mitigate sepsis-induced inflammation and improve outcomes.
Related Concept Videos
Acute Pancreatitis II: Pathophysiology
Acute Inflammation III: Local and Systemic Effects
Gastritis II: Pathophysiology
